antipyrine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

antipyrine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrahamsson, B; Knutson, L; Knutson, TW; Lennernäs, H; Lindahl, A; Sandström, R; Ungell, AL1
Fagerholm, U; Lennernäs, H; Lindahl, A1
Lennernäs, H; Lindahl, A; Sandström, R; Ungell, AL1
Echizen, H; Oishi, K; Uchida, M; Yamaguchi, T1
Aoki, E; Araki, T; Kato, H; Yano, R; Yokoyama, H1

Other Studies

5 other study(ies) available for antipyrine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Jejunal permeability and hepatic extraction of fluvastatin in humans.
    Clinical pharmacology and therapeutics, 1996, Volume: 60, Issue:5

    Topics: Adult; Antipyrine; Atenolol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Infusions, Intravenous; Intestinal Absorption; Jejunum; Liver; Male; Metoprolol; Perfusion

1996
Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms.
    The Journal of pharmacy and pharmacology, 1997, Volume: 49, Issue:7

    Topics: Administration, Oral; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Antipyrine; Atenolol; Biological Transport; Colon; Fatty Acids, Monounsaturated; Fluvastatin; Glucose; Hydrogen-Ion Concentration; Ileum; Indoles; Intestinal Absorption; Jejunum; Levodopa; Membrane Fluidity; Metoprolol; Naproxen; Perfusion; Permeability; Rats; Stereoisomerism; Structure-Activity Relationship

1997
Concentration- and region-dependent intestinal permeability of fluvastatin in the rat.
    The Journal of pharmacy and pharmacology, 1998, Volume: 50, Issue:7

    Topics: Animals; Antipyrine; Biological Transport; Colon; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Glucose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ileum; Indoles; Intestinal Absorption; Intestinal Mucosa; Jejunum; Lovastatin; Male; Rats; Rats, Sprague-Dawley

1998
Edaravone, a radical scavenger, may enhance or produce antiproliferative effects of fluvastatin, amlodipine, ozagrel, GF109203X and Y27632 on cultured basilar artery smooth muscle cells.
    Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:12

    Topics: Amides; Amlodipine; Animals; Antipyrine; Arteriosclerosis; Basilar Artery; Cell Division; Cell Survival; Cells, Cultured; Drug Synergism; Drug Therapy, Combination; Edaravone; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Indoles; Maleimides; Methacrylates; Muscle, Smooth, Vascular; Pyridines; Reactive Oxygen Species; Signal Transduction; Tetrazolium Salts; Thiazoles

2003
Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice.
    Metabolic brain disease, 2008, Volume: 23, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipyrine; Cyclooxygenase Inhibitors; Dopamine; Edaravone; Enzyme Activators; Enzyme Inhibitors; Etodolac; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Homovanillic Acid; Indazoles; Indoles; Indomethacin; Male; Mice; Mice, Inbred C57BL; Minocycline; MPTP Poisoning; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Quinolines

2008